RARE LONG-TERM SEQUELAE OF USE OF CARDIAC SEPTAL OCCLUDER DEVICE FOR TRACHEO-OESOPHAGEAL FISTULA CLOSURE IN COVID TIMES

Long-term outcomes of tracheo-esophageal fistula(TEF) closure using atrial septal defect occluder (ASDO) are unknown.

30 year male with post-tubercular TEF underwent closure using ASDO-no-10 (Waist-10mm, oesophageal-22mm, tracheal-18mm) (Lifetech scientific, Schenzen). At 4 months, gastroscopy, bronchoscopy showed partially embedded device with obliterated fistula. At 6 months, he developed COVID pneumonia and subsequently complained of recurrence of aspiration. Gastroscopy showed a patent fistulous tract with no device in situ (Video). Sudden forceful dislodgement of ASDO due to high airway pressure during a bout of cough may have led to migration. Migration of ASDO after 6 months is not previously reported in literature.

Publication History

Article published online:
14 April 2022